4 months ago
NVO
AnalystsEvan David SeigermanEvan David Seigerman's Stock Forecasts
AnalystsEvan David Seigerman
Sectors:
Industries:
Analyst Ranking
Top 28%
#1352 out of 4995 analysts
Average Return
+4.99%
Win Rate
44%20 out of 45
Risk vs Reward
Poor
Good
Evan David Seigerman's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Candel Therapeutics IncCADL | +568.75% | $1.60 | $10.70 | 2023-05-14 - 2024-05-14 | Buy |
Morphic Holding IncMORF | +147.53% | $22.49 | $55.67 | 2023-09-27 - 2024-07-09 | Buy |
Eli Lilly & CoLLY | +81.93% | $306.82 | $558.19 | 2022-09-05 - 2023-09-05 | Buy |
Acadia Pharmaceuticals IncACAD | +74.75% | $14.73 | $25.74 | 2025-04-16 - 2025-08-22 | Buy |
Regeneron Pharmaceuticals IncREGN | +41.20% | $844.37 | $1,192.23 | 2023-08-20 - 2024-08-20 | Buy |
Evan David Seigerman Analyst Color
Get additional color on Evan David Seigerman's coverage of popular stocks
7 months ago
MRK
8 months ago
NVO
2 years ago
PFE
Evan David Seigerman's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Regeneron Pharmaceuticals IncREGN | 8 | Buy | $640.00 | +8.57% | Maintains | 20 days ago |
Replimune Group IncREPL | 4 | Sell | $2.00 | -64.73% | Downgrades | a month ago |
Neurogene IncNGNE | 2 | Buy | $26.00 | +30.07% | Maintains | 2 months ago |
Merus NvMRUS | 1 | Buy | $110.00 | +62.99% | Maintains | 3 months ago |
Acadia Pharmaceuticals IncACAD | 2 | Buy | $28.00 | +8.78% | Maintains | 3 months ago |
Arvinas IncARVN | 1 | Buy | $10.00 | +36.61% | Maintains | 4 months ago |
Novo Nordisk A SNVO | 6 | Hold | $64.00 | +12.32% | Downgrades | 4 months ago |
Merck & Co IncMRK | 4 | Hold | $96.00 | +9.88% | Maintains | 7 months ago |
Abbvie IncABBV | 7 | Buy | $215.00 | +2.09% | Maintains | 7 months ago |
Amgen IncAMGN | 4 | Buy | $346.00 | +17.80% | Maintains | 7 months ago |
Morphic Holding IncMORF | 3 | Hold | $57.00 | N/A | Downgrades | a year ago |
Structure Therapeutics IncGPCR | 2 | Buy | $100.00 | N/A | Maintains | a year ago |
Pfizer IncPFE | 4 | Buy | $36.00 | N/A | Reiterates | a year ago |
Mirati Therapeutics IncMRTX | 4 | Hold | $72.00 | N/A | Maintains | 2 years ago |
Candel Therapeutics IncCADL | 1 | Buy | $3.00 | N/A | Maintains | 2 years ago |
Eli Lilly & CoLLY | 1 | Buy | $396.00 | N/A | Maintains | 3 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.